Search
Sophia Genetics SA
SOPHAdd to Watchlist
5.350USD
-0.240-4.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
384.08MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-4.29%
5 Days
-6.96%
1 Month
+7.86%
6 Months
+14.56%
Year to Date
+14.56%
1 Year
+78.93%
Key Figures
5.550Open
5.890High
386.21KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.54%Turnover Ratio
5.590Prev. Close
5.250Low
1.51MTurnover
LossP/E Static
8.41P/B
0.00%Div Yield TTM
-53.30%ROA
5.70052wk High
1.42Volume Ratio
-62.49MNet Profit
71.79MShares
-1.1812EPS TTM
0.99Beta
-123.28%ROE
2.59052wk Low
11.45%Amplitude
68.01%Gross Margin
384.08MMarket Cap
2.96Reward/Risk
4.30%Risk Rate
TradingKey Stock Score of Sophia Genetics SA
Currency: USD Updated: 2026-07-02Key Insights
Sophia Genetics SA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 162 out of 486 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 8.00.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sophia Genetics SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sophia Genetics SA Highlights
StrengthsRisks
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.89% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 77.27M.
Undervalued
The company’s latest PE is -4.53, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 27.73M shares, decreasing 30.02% quarter-over-quarter.
Held by Akre Capital Management
Star Investor Akre Capital Management holds 3.62M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.22.
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
8.000
Target Price
+43.11%
Upside Space
Sophia Genetics SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Sophia Genetics SA Info
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Ticker SymbolSOPH
CompanySophia Genetics SA
CEOCamblong (Jurgi)
Websitehttps://www.sophiagenetics.com/
Related Instruments
-0.36%
-0.48%
+1.62%
-4.90%
+2.99%
+3.24%
-1.64%
+4.66%
+2.84%
+1.03%
-1.13%
-1.87%
+2.17%
-6.65%
-1.78%
+2.42%
+1.76%
-0.16%
-1.72%
+0.34%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Sophia Genetics SA (SOPH)?
The current price of Sophia Genetics SA (SOPH) is 5.35.
What is the symbol of Sophia Genetics SA?
The ticker symbol of Sophia Genetics SA is SOPH.
What is the 52-week high of Sophia Genetics SA?
The 52-week high of Sophia Genetics SA is 5.70.
What is the 52-week low of Sophia Genetics SA?
The 52-week low of Sophia Genetics SA is 2.59.
What is the market capitalization of Sophia Genetics SA?
The market capitalization of Sophia Genetics SA is 384.08M.
Is Sophia Genetics SA (SOPH) currently rated as Buy, Hold, or Sell?
According to analysts, Sophia Genetics SA (SOPH) has an overall rating of STRONG BUY, with a price target of 8.00.
What is the Earnings Per Share (EPS TTM) of Sophia Genetics SA (SOPH)?
The Earnings Per Share (EPS TTM) of Sophia Genetics SA (SOPH) is -1.17.